OR4D11 Inhibitors
OR4D11 Inhibitors are compounds that indirectly lead to the functional inhibition of the olfactory receptor family D member 11 (OR4D11), a G protein-coupled receptor (GPCR). These inhibitors operate by targeting various signaling molecules and pathways that are upstream or integral to the functional activity of OR4D11. For instance, Chloroquine raises lysosomal pH, disrupting the degradation process that could be responsible for the turnover of OR4D11. By hindering this degradation, Chloroquine potentially leads to the accumulation of dysfunctional OR4D11, thereby inhibiting its activity. Similarly, Genistein targets tyrosine kinases that may phosphorylate OR4D11 or its interacting partners, which is a prerequisite for OR4D11 to signal effectively. Without these phosphorylation events, OR4D11 signaling could be impaired.
Inhibitors like Gö 6983 and PD 169316 disrupt specific kinase activities (PKC and p38 MAPK, respectively) that, if involved in OR4D11 signaling pathways, could lead to inhibition of OR4D11 function. Gö 6983 would prevent the phosphorylation by PKC, which might be critical for OR4D11 signaling or receptor turnover, while PD 169316 would block the p38 MAPK activity, potentially preventing the receptor from engaging in its normal signaling events.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is a known autophagy inhibitor that raises the pH in lysosomes, leading to inhibition of lysosomal enzymes that require an acidic pH to function. If OR4D11 is degraded by lysosomal pathways, chloroquine can indirectly inhibit OR4D11 by preventing its degradation in the lysosome. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can interfere with phosphorylation events critical for various signaling pathways. If OR4D11 function is dependent on tyrosine kinase activity for signal transduction, genistein can inhibit OR4D11 activity by blocking the phosphorylation it needs to function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a potent protein kinase C (PKC) inhibitor that can reduce the activity of PKC isoforms. If OR4D11 signaling is mediated through a PKC-dependent pathway, Gö 6983 can indirectly inhibit OR4D11 by preventing PKC activation and subsequent signaling events. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
PD 169316 is a specific inhibitor of p38 MAPK, which is involved in cellular responses to stress and inflammation. If OR4D11 utilizes p38 MAPK in its signaling cascade, PD 169316 can indirectly inhibit OR4D11 by blocking this kinase's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that prevents the phosphorylation and activation of downstream AKT. If OR4D11 is coupled to PI3K/AKT signaling pathways, LY294002 can inhibit OR4D11 by preventing the PI3K-induced activation of AKT that may be necessary for OR4D11's function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. If OR4D11's activity is regulated by the ERK signaling pathway, U0126 can inhibit OR4D11 indirectly by inhibiting MEK1/2 and preventing ERK activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can suppress the PI3K/AKT pathway. Similar to LY294002, if OR4D11's function is associated with this pathway, wortmannin can inhibit OR4D11 by preventing the activation of AKT. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 is a specific inhibitor of p38 MAPK, similar to PD 169316. If OR4D11 is part of a signaling cascade that involves p38 MAPK, SB203580 can inhibit OR4D11 by hindering the kinase activity of p38 MAPK. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
ZM 336372 is a potent RAF kinase inhibitor, which could disrupt the MAPK/ERK pathway. If OR4D11 is involved in signaling that requires RAF kinase activity, ZM 336372 can inhibit OR4D11 by inhibiting RAF and subsequent MAPK/ERK signaling. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
Dactolisib is a dual PI3K/mTOR inhibitor that can suppress both PI3K/AKT and mTOR signaling pathways. If OR4D11 signaling is linked with these pathways, dactolisib can inhibit OR4D11 by preventing the activation of both PI3K/AKT and mTOR pathways. | ||||||